23 Jul, 2026
According to Straits Research the global clinical trial logistics market size was valued at $5.32 billion in 2025 and is projected to grow from $5.79 billion in 2026 to $11.81 billion by 2034, registering a CAGR of 9.30% during the forecast period (2026–2034).
The clinical trial logistics market is driven by the expansion of global clinical programs that rely on coordinated distribution routes, controlled storage conditions, and structured shipment planning to support rising trial volumes across oncology, metabolic disorders, rare diseases, and advanced biological therapies. A key restraint for the market stems from the complexity of complying with varied regulatory procedures across countries, which introduces delays in customs clearance, documentation review, and temperature-controlled transport for sensitive investigational products. An opportunity emerges from the rapid development of regional depots, specialized storage hubs, and distribution centers that bring clinical materials closer to trial sites, enabling smoother site activation, faster resupply cycles, and broader participation in decentralized and hybrid study models.
North America currently dominates the global Clinical Trial Logistics Market due to its well-established pharmaceutical industry, advanced healthcare infrastructure, and large number of ongoing clinical trials. Asia-Pacific is expected to register the fastest growth during the forecast period, supported by increasing research activities, improving healthcare facilities, and rising investments from global pharmaceutical companies. Continuous expansion of cold-chain infrastructure and warehouse networks is further strengthening regional market growth.
sales@straitsresearch.com